SEC filing record
Primary Source · SEC.gov

Salus Scientific Corp.

2026 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2026-10-225 events: 3 new form d filer, 1 offering upsized, 1 sold increasedLast filing 2026-10-22

Raised

Pre-open

Investors

—

Min Invest

$250,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Salus Scientific Corp. is a South Carolina corporation organized in 2021 that first filed a Form D on November 10, 2022 and most recently amended it on October 22, 2026 in the Other Health Care industry group. The offering claims Rule 506(b) and covers equity. Salus Scientific Corp. reported that the first sale had not yet occurred as of the Form D filed October 22, 2026, so no amount sold or investor count is on file. The total offering amount is $30,000,000. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000. The Form D names Jeffrey S. Goodman (CRD 002607530), associated with Ankura Capital Advisors, LLC as the recipient of sales compensation. Sales commissions are reported as $1,300,000 and finders' fees as $0. Form D allows these to be estimates. The issuer reports $900,000 of gross proceeds used or proposed to be used for payments to related persons. The issuer's address of record is 229 Huger St., 3rd Floor, Charleston, SC 29403.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001952070
Entity NameSalus Scientific Corp.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationSouth Carolina
Year Organized2021
Issuer Address229 Huger St., 3rd Floor, Charleston, SC 29403
Phone(877) 467-2587
Industry / Fund TypeOther Health Care
Securities TypeEquity
First Sale DateNot yet occurred (as filed)
Filing DateOctober 22, 2026
Accession Number0001085146-26-000912
Total Offering Amount$30,000,000
Total Amount Sold$0 (no sales yet)
Amount Remaining$30,000,000
Total Investors0 (no sales yet)
Non-Accredited InvestorsNone
Minimum Investment$250,000
Offering DurationOne year or less
Sales Commissions$1,300,000 (to Jeffrey S. Goodman)
Finders' Fees$0
Proceeds to Related Persons$900,000
Revenue RangeDecline to Disclose
State (Issuer Address)SC
Amendment Count5 filings on record
Signed ByJon A. Wallace, Officer General Counsel

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

5

latest Oct 22, 2026

Critical / warning

0 / 0

1 watch · 4 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

4

pre_sale, closed, lapsed

Latest event New filer · Oct 22, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 5 filing events with values and deltas, latest 2026-10-22, and alerts on the next one
  • 4 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Item 3 changed on the Form D filed 2026-10-22: 3 related persons added and 1 removed against the filing of 2026-08-05; 8 now listed. The names are in the Terminal feed.

Todd Flohr

Executive Officer, Director · Charleston, SC

Keith Rosmarin

Executive Officer · Charleston, SC

Jon Wallace

Executive Officer, Director · Charleston, SC

William Buchanan

Director · Charleston, SC

Ryan Majoria

Director · Charleston, SC

Ronald Sancho

Director · Charleston, SC

C. William Martin

Director · Charleston, SC

Richard Moore

Director · Charleston, SC

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Jeffrey S. GoodmanCRD 002607530 on BrokerCheck

Associated broker-dealer: Ankura Capital Advisors, LLC (CRD 000114155) · New York, NY

Questions About Salus Scientific Corp.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Salus Scientific Corp.?

Salus Scientific Corp. is a South Carolina corporation organized in 2021 that filed a Form D with the SEC on October 22, 2026 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.

Is Salus Scientific Corp. legit?

AltStreet does not rate legitimacy; it reports the public record. Salus Scientific Corp. filed a Form D with the SEC on October 22, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. No sales had been reported as of that notice. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Salus Scientific Corp. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Salus Scientific Corp. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Salus Scientific Corp. raised?

Salus Scientific Corp. reported that the first sale had not yet occurred as of the Form D filed October 22, 2026, so no amount sold or investor count is on file. The total offering amount is $30,000,000.

Who can invest in Salus Scientific Corp.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.

What is the minimum investment in Salus Scientific Corp.?

The Form D lists $250,000 as the minimum investment accepted from any outside investor as of October 22, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling Salus Scientific Corp. and how are they paid?

The Form D names Jeffrey S. Goodman (CRD 002607530), associated with Ankura Capital Advisors, LLC as the recipient of sales compensation. Sales commissions are reported as $1,300,000 and finders' fees as $0. Form D allows these to be estimates. The issuer reports $900,000 of gross proceeds used or proposed to be used for payments to related persons.

Who is behind Salus Scientific Corp.?

The Form D lists 8 related persons: Todd Flohr, executive officer, director; Keith Rosmarin, executive officer; Jon Wallace, executive officer, director; William Buchanan, director; Ryan Majoria, director; Ronald Sancho, director; C. William Martin, director; Richard Moore, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Salus Scientific Corp. located?

The issuer's address on its SEC filings is 229 Huger St., 3rd Floor, Charleston, SC 29403. Its phone number of record is 877-467-2587. It is organized under the laws of South Carolina.

How long is the Salus Scientific Corp. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.

What is Salus Scientific Corp.'s revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.